# EDGAR Filing Document

**Accession Number:** 0001976443
**File Stem:** 0001213900-25-077446
**Filing Date:** 2025-8
**Character Count:** 28924
**Document Hash:** 90c9c46a739d81644e689b0e9da1454d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-077446.hdr.sgml**: 20250815

**ACCESSION NUMBER**: 0001213900-25-077446

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20250815

**FILED AS OF DATE**: 20250815

**DATE AS OF CHANGE**: 20250815

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Silynxcom Ltd.
- **CENTRAL INDEX KEY:** 0001976443
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD AUDIO & VIDEO EQUIPMENT [3651]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41916
- **FILM NUMBER:** 251224645

**BUSINESS ADDRESS:**
- **STREET 1:** 7 GIBOREI ISRAEL
- **CITY:** NETANYA
- **STATE:** L3
- **ZIP:** 4250407
- **BUSINESS PHONE:** 97298658370

**MAIL ADDRESS:**
- **STREET 1:** 7 GIBOREI ISRAEL
- **CITY:** NETANYA
- **STATE:** L3
- **ZIP:** 4250407

#### UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION<br>WASHINGTON, D.C. 20549
**_________________**

#### FORM 6-K
**_________________**

#### REPORT OF FOREIGN PRIVATE ISSUER<br> PURSUANT TO RULE 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934

#### For the month of August 2025

#### Commission File Number: 001-41916
**_________________**

#### Silynxcom Ltd.
**_________________**

#### 7 Giborei Israel<br>Netanya, 4250407<br>Israel<br> (Address of principal executive office)
**_________________**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    <u> Form 20-F </u>   <u> ☒ </u>       <u> Form 40-F </u>   <u> ☐ </u>    

------

#### CONTENTS
Attached hereto and incorporated herein are Silynxcom Ltd.'s (the "Company") Notice of Special General Meeting of Shareholders, Proxy Statement and Form of Proxy Card for the Special General Meeting of Shareholders to be held on September 3, 2025 (the "Meeting").

Only shareholders of record who hold ordinary shares, no par value per share, of the Company at the close of business on August 25, 2025, will be entitled to notice of and to vote at the Meeting and any postponements or adjournments thereof.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company's Registration Statement on [<u>Form F</u>-3](http://www.sec.gov/Archives/edgar/data/1976443/000121390025018813/ea0232129-f3_silynxcom.htm) (Registration No. 333-285443) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

#### EXHIBIT INDEX

---

| | |
|:---|:---|
|  **Exhibit No.** | **Description** |
|  99.1 | [<u>Notice of Meeting for the Special General Meeting of Shareholders</u>](ea025350201_silynxcomex99-1.htm) |
|  99.2 | [<u>Proxy Statement for the Special General Meeting of Shareholders</u>](ea025350201_silynxcomex99-2.htm) |
|  99.3 | [<u>Form of Proxy Card for the Special General Meeting of Shareholders</u>](ea025350201_silynxcomex99-3.htm) |

---

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **SILYNXCOM LTD.** | **SILYNXCOM LTD.** |
|  Date: August 15, 2025 | By: | /s/ Nir Klein |
|  | Name:  | Nir Klein |
|  | Title: | Chief Executive Officer |

---

## Exhibit 99.1

#### Exhibit 99.1
**SILYNXCOM Ltd.<br>Notice of SPECIAL General Meeting of shareholders**

Notice is hereby given that a Special General Meeting of Shareholders (the "**Meeting**") of Silynxcom Ltd. (the "**Company**") will be held on September 3, 2025 at 5 p.m. Israel time, at the Company's office, located at 7 Giborei Israel, Netanya, 4250407, Israel.

<u>The agenda of the Meeting includes the following proposals (the "</u>**<u>Proposals</u>**<u>")</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association (the "**Articles**") to reflect the same; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. To consider a reverse split of the Company's issued and outstanding ordinary shares, no par value per share (the "**Ordinary Shares**"), at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by, the Company's board of directors (the "**Board**"), and to amend the Articles to reflect the same.

***Board Recommendation***

The Board unanimously recommends that you vote "**FOR**" of each of the proposed resolutions, which are described in the attached proxy statement (the "**Proxy Statement**").

***Record Date***

Shareholders of record at the close of business on August 25, 2025 (the "**Record Date**"), are entitled to notice of and to vote at the Meeting, either in person or by appointing a proxy to vote in their stead at the Meeting (as detailed below).

***Required Vote and Voting Procedures***

The Proposals to be presented at the Meeting each require a Simple Majority, as defined in the Proxy Statement, of votes in person or by proxy at the Meeting.

***How You Can Vote***

A form of proxy card for use at the Meeting is attached to the accompanying Proxy Statement, together with a return envelope, being sent to holders of the Company's Ordinary Shares. By appointing "proxies," (in accordance with the Articles and applicable law) shareholders may vote at the Meeting regardless of whether they attend. If a properly executed proxy card in the attached form is received by the Company at least four (4) hours prior to the Meeting, all of the Ordinary Shares represented by the proxy shall be voted as indicated on the form.

Shareholders may revoke their proxies or voting instruction forms (as applicable), in accordance with Section 9 of the Companies Law 5759-1999 (proxy and position statements), by filing with the Company a written notice of revocation or duly executed proxy or voting instruction form (as applicable) bearing a later date and time.

*Shareholders of Record*

If your shares are registered directly in your name with our transfer agent, VStock Transfer, LLC, you are considered, concerning those shares, the shareholder of record. In such case, these proxy materials are being sent directly to you. As the shareholder of record, you have the right to use the proxy card included with this **Proxy Statement** to grant your voting proxy (according to the Company's Articles) or send your proxy card directly to Mr. Nir Klein, Chief Executive Officer of the Company (kleinnir@s-o-s.co.il), and Mr. Ilan Akselrod, Chief Financial Officer of the Company (ilan@s-o-s.co.il), or to vote in person at the Meeting.

Subject to applicable law and the rules of the NYSE American, LLC, in the absence of instructions, the Ordinary Shares represented by properly executed and received proxies will be voted "**FOR**" all of the proposed resolutions to be presented at the Meeting for which the Board recommends a "**FOR**".

*Beneficial Owner*

If your shares are held through a bank, broker or other nominee, they are considered to be held in "street name" and you are the beneficial owner with respect to those shares. A beneficial owner as of the Record Date has the right to direct the bank, broker or nominee how to vote shares held by such beneficial owner at the Meeting, and must also provide the Company with a copy of their identity card, passport or certification of incorporation, as the case may be. If your shares are held in "street name," as of the Record Date, these proxy materials are being forwarded to you by your bank, broker or nominee who is considered, with respect to those shares, as the shareholder of record, together with a voting instruction card for you to use in directing the bank, broker or nominee how to vote your shares. You also may attend the Meeting. Because a beneficial owner is not a shareholder of record, you may not vote those shares directly at the Meeting unless you obtain a "legal proxy" from the bank, broker or other nominee that holds your shares directly, giving you the right to vote the shares at the Meeting.

---

| |
|:---|
|  Sincerely, |
|  /s/ Ron Klein |
|  Ron Klein |
|  *Chairman of the Board of Directors* |
|  August 15, 2025 |

---

## Exhibit 99.2

#### Exhibit 99.2
**SILYNXCOM LTD.<br>NETANYA, ISRAEL**

**PROXY STATEMENT**

**SPECIAL GENERAL MEETING OF SHAREHOLDERS<br>TO BE HELD ON SEPTEMBER 3, 2025**

The enclosed Proxy Statement is being solicited by the board of directors (the "**Board**") of Silynxcom Ltd. (the "**Company**") for use at the Company's special general meeting of shareholders (the "**Meeting**") to be held on September 3, 2025, at 5 p.m. Israel time, or at any adjournment or postponement thereof, at the Company's office, located at 7 Giborei Israel, Netanya, 4250407, Israel.

Upon the receipt of a properly executed proxy in the form enclosed, the persons named as proxies therein will vote the ordinary shares, no par value per share, of the Company (the "**Ordinary Shares**"), covered thereby in accordance with the directions of the shareholders executing the proxy. In the absence of such directions, and except as otherwise mentioned in this proxy statement ("**Proxy Statement**"), the Ordinary Shares represented thereby will be voted "**FOR**" each of the proposals described in this Proxy Statement (the "**Proposals**").

***Quorum and Adjournment***

Two or more shareholders present, in person or by proxy, holding in the aggregate not less than twenty-five percent (25%) of the Company's outstanding Ordinary Shares, shall constitute a quorum for the Meeting. If within half an hour from the time the Meeting is convened a quorum is not present, the Meeting shall be adjourned until September 3, 2025, at 7 p.m. Israel time (the "**Adjourned Meeting**"). At the Adjourned Meeting, any number of shareholders present in person or by proxy shall be deemed a quorum and shall be entitled to deliberate and to resolve in respect of the matters for which the Meeting was convened. Abstentions and broker non-votes are counted as Ordinary Shares present for the purpose of determining a quorum.

***Vote Required for Approval of the Proposals***

Pursuant to the Israeli Companies Law, 5759-1999 (the "**Companies Law**"), the Proposals described hereinafter require the affirmative vote of shareholders present at the Meeting, in person or by proxy, and holding Ordinary Shares of the Company amounting in the aggregate to at least a majority of the votes actually cast by shareholders with respect to such Proposals (a "**Simple Majority**").

***Proposed Additional Agenda Items***

In accordance with the Companies Law, and regulations promulgated thereunder, any shareholder of the Company holding at least 1% of the outstanding voting rights of the Company for the Meeting may submit to the Company a proposed additional agenda item for the Meeting (and in case of a proposed additional agenda item for nominating or removal of a director, at least 5% (five percent) of the outstanding voting rights of the Company) to Mr. Nir Klein, Company's Chief Executive Officer and director; e-mail address: kleinnir@s-o-s.co.il, no later than August 25, 2025. All such submissions must comply with the requirements under the Companies Law, the regulations promulgated thereunder, and the Company's amended and restated articles of association (the "**Articles**").

There may be changes on the agenda after publishing the Proxy. Therefore, the most updated agenda will be furnished to the SEC on a Report of Foreign Private Issuer on Form 6-K and will be made available to the public on the SEC's website at *www.sec.gov.*

#### PROPOSAL 1

#### TO INCREASE THE COMPANY'S REGISTERED SHARE CAPITAL AND TO AMEND AND RESTATE THE COMPANY'S CURRENT ARTICLES TO REFLECT THE SAME
As of the date hereof, the Company's authorized share capital consists of 50,000,000 Ordinary Shares.

On August 14, 2025, the Board approved an increase to the Company's authorized share capital by 1,950,000,000 Ordinary Shares (the "**Increase of Authorized Share Capital**"). Accordingly, after giving effect to the Increase of Authorized Share Capital, the authorized share capital of the Company will consist of 2,000,000,000 Ordinary Shares.

The Board believes the Increase of Authorized Share Capital is necessary to enable the Company to have sufficient authorized share capital and to ensure that the Company can raise adequate capital so that it can pursue business opportunities to meet any potential future business needs and better position the Company for potential future financing and strategic transactions. Additionally, as a general matter, such Increase of Authorized Share Capital would enable the Board to issue additional Ordinary Shares in its discretion from time to time for general corporate purposes.

An amendment to the Articles that reflects the Increase of Authorized Share Capital, will be as follows:

*"5. Authorized Share Capital.*

*(a) The share capital of the Company shall consist of 2,000,000,000 Ordinary Shares, no par value each (the "****Shares****")."*

The Board believes that the Increase of the Authorized Share Capital is advisable and in the best interests of the Company's shareholders.

The Company's shareholders are requested to adopt the following resolution:

**"RESOLVED, to approve to increase to the Company's authorized share capital by 1,950,000,000 Ordinary Shares to 2,000,000,000 Ordinary Shares, and to amend and restate the Articles to reflect the same, as set forth in Proposal 1 of the Proxy Statement."**

The approval the Proposal, as described above, requires the affirmative vote of a Simple Majority.

**The Board unanimously recommends that the shareholders vote "FOR" the above Proposal.**

**PROPOSAL 2**

**TO APPROVE A REVERSE SPLIT OF THE COMPANY'S ISSUED AND OUTSTANDING <br>ORDINARY SHARES AT A RATIO OF BETWEEN 2:1 AND 20:1, TO BE IN EFFECT, IF <br>EFFECTED, AT THE DISCRETION OF, AND AT SUCH DATE TO BE DETERMINED BY, THE BOARD**

The Board believes that having discretion to decide whether to effectuate a reverse share split is advisable in order to make the Company's Ordinary Shares more attractive to a broader range of investors and to better position the Company for potential future financings and strategic transactions.

Therefore, on August 14, 2025, the Board approved, subject to the approval of the general meeting of the Company's shareholders, a framework for a potential adjustment of the Company's share capital at a ratio of between 2-for-1 and 20-for-1, with respect to the Company's issued and outstanding Ordinary Shares, such that every two (2) to twenty (20) Ordinary Shares shall be converted into one (1) Ordinary Share, and/or any Ordinary Shares issuable pursuant to exercise or conversion of outstanding options, restricted share units and/or warrants issued by the Company, to be effected, if effected, at the discretion of, and at such date to be determined by the Board (the "**Reverse Split**").

If the Reverse Split is approved, then the Board will have the authority, at its own discretion, to determine whether to effect the Reverse Split, and the exact ratio and the effective date of the Reverse Split. Following such determination by the Board, the Company will issue a press release announcing the effective date and the ratio of the Reverse Split.

The Board believes that approval of a proposal providing the Board with this generalized grant of authority with respect to setting the Reverse Split ratio, rather than just the approval of a pre-defined reverse share split, will give the Board the flexibility to set the ratio in accordance with current market conditions and, therefore, allow the Board to act in the best interests of the Company and its shareholders.

The implementation of the Reverse Split will result in the reduction of the number of the issued and outstanding Ordinary Shares in accordance with the exchange ratio (between 2:1 and 20:1), such that if the Reverse Split is approved, depending on the ratio, every two (2) Ordinary Shares and up to twenty (20) Ordinary Shares, issued and outstanding, shall be converted into one (1) Ordinary Share. The Reverse Split, if effected, would not adjust the authorized share capital of the Company under its Articles, which, as of the date hereof, consists of 50,000,000 Ordinary Shares or will consist of 2,000,000,000 Ordinary Shares, subject to approval of Proposal 1 in this Meeting.

In addition, if the Reverse Split is effected, the exercise price and the number of Ordinary Shares issuable upon the exercise of any outstanding options, restricted share units and/or warrants will be proportionately adjusted pursuant to the terms of the respective securities in connection with the Reverse Split. Furthermore, upon completion of the Reverse Split, the number of Ordinary Shares and/or any options or restricted share units available for issuance under the Company's 2022 Equity Reward Plan shall be appropriately adjusted.

The Reverse Split, if effected, will be effected simultaneously for all of the Company's securities, and the exchange ratio will be the same for all securities. The Reverse Split will affect all the Company's shareholders uniformly and will not affect any shareholder's percentage ownership interests in the Company, relative voting rights or other rights. Ordinary Shares resulting from such Reverse Split will remain fully paid and non-assessable.

No fractional shares will be issued as a result of the Reverse Split. In accordance with the Company's Articles, all fractional shares will be rounded to the nearest whole Ordinary Share, such that only shareholders holding fractional consolidated shares of more than half of the number of shares which consolidation constitutes one whole share, shall be entitled to receive one consolidated share.

Upon the implementation of the Reverse Split, the Company intends to treat shares held by shareholders through a bank, broker, custodian, or other nominee in the same manner as registered shareholders whose shares are registered in their names. Banks, brokers, custodians, or other nominees will be instructed to effect the Reverse Split for their beneficial holders holding the Company's Ordinary Shares in street name. However, these banks, brokers, custodians, or other nominees may have different procedures than registered shareholders for processing the Reverse Split. Shareholders who hold the Company's Ordinary Shares with a bank, broker, custodian or other nominee and who have any queries in this regard are encouraged to contact their banks, brokers, custodians or other nominees.

While the Board believes that the potential advantages of a Reverse Split outweigh any actual or potential disadvantages, if the Company does effect a Reverse Split there can be no assurance that: (i) the Company's Ordinary Shares will trade at a price in proportion to the decrease in the number of outstanding shares resulting from the Reverse Split; (ii) the liquidity of the Company's Ordinary Shares will not be adversely affected by the reduced number of shares that would be outstanding and available for trading after the Reverse Split; (iii) engaging in a Reverse Split will not be perceived in a negative manner by investors, analysts or other stock market participants; or (iv) the Reverse Split will not result in some shareholders owning "odd-lots" of fewer than 100 Ordinary Shares, potentially resulting in higher brokerage commissions and other transaction costs than the commissions and costs of transactions in "round-lots" of even multiples of 100 shares.

THE U.S. AND ISRAELI TAX CONSEQUENCES OF THE REVERSE SPLIT MAY DEPEND UPON THE PARTICULAR CIRCUMSTANCES OF EACH SHAREHOLDER. ACCORDINGLY, EACH SHAREHOLDER IS ADVISED TO CONSULT THEIR TAX ADVISOR WITH RESPECT TO ALL OF THE POTENTIAL TAX CONSEQUENCES TO THE SHAREHOLDER OF THE REVERSE SPLIT.

The Board believes that the Reverse Split is appropriate and in the best interest of the Company's shareholders.

The Company's shareholders are requested to adopt the following resolution:

**"RESOLVED, to approve a reverse share split of the Company's issued and outstanding Ordinary Shares at a ratio of between 2:1 and 20:1, to be effected, if effected, at the discretion of and on such date to be determined by the Board, as set forth in Proposal 2 of the Proxy Statement".**

The approval of this proposal requires the affirmative vote of a Simple Majority (as defined in this Proxy Statement).

**The Board unanimously recommends that the shareholders vote FOR the above proposal.**

**OTHER BUSINESS**

**Your vote is important!** Shareholders are urged to complete and return their proxies promptly in order to, among other things, ensure action by a quorum and to avoid the expense of additional solicitation. If the accompanying proxy is properly executed and returned in time for voting, and a choice is specified, the shares represented thereby will be voted as indicated thereon. EXCEPT AS MENTIONED OTHERWISE IN THIS PROXY STATEMENT, IF NO SPECIFICATION IS MADE, THE PROXY WILL BE VOTED "FOR" THE PROPOSALS DESCRIBED IN THIS PROXY STATEMENT.

**Proxies and all other applicable materials should be sent to:**

VStock Transfer, LLC<br>18 Lafayette Pl<br>Woodmere, New York 11598<br>United States of America

**ADDITIONAL INFORMATION**

The Board is not aware of any other matters that may be presented at the Meeting other than those described in this Proxy Statement. If any other matters do properly come before the Meeting, including the authority to adjourn the Meeting, it is intended that the persons named as proxies will vote, pursuant to their discretionary authority, according to their best judgment in the interest of the Company.

The Company is subject to the informational requirements of the U.S. Securities Exchange Act of 1934, as amended (the "**Exchange Act**"), as applicable to foreign private issuers. Accordingly, the Company files reports and other information with the SEC. All documents which the Company files on the SEC's EDGAR system will be available for retrieval on the SEC's website at *http://www.sec.gov.*

As a foreign private issuer, the Company is exempt from the rules under the Exchange Act prescribing certain disclosure and procedural requirements for proxy solicitations. In addition, the Company is not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as United States companies whose securities are registered under the Exchange Act. The Notice of the Special General Meeting of Shareholders and the proxy statement have been prepared in accordance with applicable disclosure requirements in the State of Israel.

YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROXY STATEMENT OR THE INFORMATION FURNISHED TO YOU IN CONNECTION WITH THIS PROXY STATEMENT WHEN VOTING ON THE MATTERS SUBMITTED TO SHAREHOLDER APPROVAL HEREUNDER. THE COMPANY HAS NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS DOCUMENT. THIS PROXY STATEMENT IS DATED AUGUST 15, 2025. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS DOCUMENT IS ACCURATE AS OF ANY DATE OTHER THAN AUGUST 15, 2025, AND THE MAILING OF THIS DOCUMENT TO SHAREHOLDERS SHOULD NOT CREATE ANY IMPLICATION TO THE CONTRARY.

---

| |
|:---|
|  By Order of the Board of Directors |
|  Silynxcom Ltd. |
|  /s/ Ron Klein |
|  Ron Klein, <br>Chairman of the Board of Directors |

---

## Exhibit 99.3

#### Exhibit 99.3
 **SILYNXCOM LTD.**<br>

#### PROXY CARD

#### THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Mr. Ilan Akselrod, Chief Financial Officer of Silynxcom Ltd. (the "**Company**"), Mr. Nir Klein, Chief Executive Officer and director of the Company, and each of them, agents and proxies of the undersigned, with full power of substitution to each of them, to represent and to vote on behalf of the undersigned all the ordinary shares, no par value, of the Company (the "**Ordinary Shares**") which the undersigned is entitled to vote at the Special General Meeting of Shareholders (the "**Meeting**") to be held on September 3, 2025 at 5 p.m. Israel time, at the Company's office, located at 7 Giborei Israel, Netanya, 4250407, Israel, and at any adjournments or postponements thereof, upon the following matters, which are more fully described in the Notice of Special General Meeting of Shareholders and Proxy Statement relating to the Meeting (the "**Proxy Statement**").

This proxy, when properly executed, will be voted in the manner directed herein by the undersigned. If no direction is made with respect to any matter, this proxy will be voted FOR such matter. Any and all proxies heretofore given by the undersigned are hereby revoked.

**(Continued and to be signed on the reverse side)**

------

#### SILYNXCOM LTD.<br>SPECIAL GENERAL MEETING OF SHAREHOLDERS
Date of Meeting: September 3, 2025

PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE<br>MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE ☒

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| 1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association to reflect the same. | 1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association to reflect the same. | 1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association to reflect the same. | 1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association to reflect the same. | 1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association to reflect the same. | 1. To increase the Company's registered share capital and to amend and restate the Company's current amended and restated articles of association to reflect the same. |
| &nbsp;&nbsp;&nbsp; ☐ | **FOR** | ☐ | **AGAINST** | ☐ | **ABSTAIN** |
| 2. To approve a reverse split of the Company's issued and outstanding Ordinary Shares, at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by the Company's board of directors. | 2. To approve a reverse split of the Company's issued and outstanding Ordinary Shares, at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by the Company's board of directors. | 2. To approve a reverse split of the Company's issued and outstanding Ordinary Shares, at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by the Company's board of directors. | 2. To approve a reverse split of the Company's issued and outstanding Ordinary Shares, at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by the Company's board of directors. | 2. To approve a reverse split of the Company's issued and outstanding Ordinary Shares, at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by the Company's board of directors. | 2. To approve a reverse split of the Company's issued and outstanding Ordinary Shares, at a ratio between 2:1 and 20:1, to be in effect, if effected, at the discretion of, and at such date to be determined by the Company's board of directors. |
| &nbsp;&nbsp;&nbsp; ☐ | **FOR** | ☐ | **AGAINST** | ☐ | **ABSTAIN** |

---

---

| | | |
|:---|:---|:---|
|  NAME | SIGNATURE | DATE |
|  NAME | SIGNATURE | DATE |

---

In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the Meeting or any adjournment or postponement thereof.

Please sign exactly as your name appears on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, trustee or guardian, please give full title as such. If the signed is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.

------